Clinical trials
Phase 1/2 Myelodysplastic Syndromes trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 5 |
| Completed | 3 |
| Recruiting | 3 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Akeso | 1 |
| BeOne Medicines | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| Chinese PLA General Hospital | 1 |
| ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 1 |
| Karyopharm Therapeutics Inc | 1 |
| Mabwell (Shanghai) Bioscience Co., Ltd. | 1 |
| Maxinovel Pty., Ltd. | 1 |
| Otsuka Beijing Research Institute | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 18 |
| Leukemia, Myeloid, Acute | 9 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Colorectal Neoplasms | 1 |
| Hematologic Neoplasms | 1 |
| Leukemia | 1 |
| Leukemia, Myelomonocytic, Chronic | 1 |
| Lymphoma | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| Multiple Myeloma | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.